FindTrial
Sign In

Constraints for symptomatic radiation pneumonitis in patients with unresectable non-small cell lung cancer receiving moderately hypo-fractionated helical tomotherapy

Constraints for symptomatic radiation pneumonitis in patients with unresectable non-small cell lung cancer receiving moderately hypo-fractionated helical tomotherapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046069
Enrollment
Unknown
Registered
2021-05-03
Start date
2021-05-06
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

case series:No

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Unresectable non-small cell lung cancer newly diagnosed by pathology; 2. Receive moderate-dose low-fraction TOMO radiotherapy (54-70.4 Gy, 2.3-3.0 Gy/time); 3. There are complete clinical, dosimetry and follow-up information after radiotherapy.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
Symptomatic radiation pneumonitis (R;—

Countries

China

Contacts

Public ContactZeng Zhaochong

Zhongshan Hospital, Fudan University

zeng.zhaochong@zs-hospital.sh.cn+86 13817076800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026